Ketalar

Ketamine, the active ingredient in Ketalar, is a dissociative anesthetic presented as a sterile injectable solution for intramuscular and intravenous use. It is employed to induce anesthesia, provide analgesia, and achieve procedural sedation in surgical and diagnostic settings for patients, under controlled medical supervision and monitoring.

GNH USA supplies Ketalar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on reliable quality and regulatory compliance. The company ensures timely delivery and supports customers with technical and regulatory assistance.

Ketamine is a dissociative anesthetic that acts on the central nervous system via NMDA receptor antagonism, providing rapid loss of consciousness and analgesia.

Induction of anesthesia: produces a controlled state of unconsciousness for surgical procedures. Analgesia: delivers potent pain relief during and after operative or diagnostic interventions. Sedation: facilitates procedural sedation for short‑duration examinations or minor surgeries.

Ketamine may cause a range of adverse reactions, varying from mild to severe, depending on dose and patient factors.

Common Side Effects: - Dizziness - Nausea - Vomiting - Increased salivation

Serious or Rare Side Effects: - Respiratory depression - Emergence delirium - Hallucinations

When using Ketalar, clinicians should observe specific safety measures to minimize risks and ensure optimal patient outcomes.

Monitor cardiovascular status: observe blood pressure and heart rate for hypertension or tachycardia. Assess airway patency: ensure airway is protected due to potential loss of reflexes. Avoid use in severe psychiatric disorders: risk of psychotomimetic reactions. Use lowest effective dose: limit exposure to reduce side effects. Adjust dose in hepatic impairment: metabolism may be reduced. Store at ambient temperature: keep in original container, protect from light and moisture.

Ketamine can interact with other medicines, altering its effects or increasing the risk of adverse events.

Major Interactions (Avoid): - Opioids and other central nervous system depressants - Monoamine oxidase inhibitors - Sympathomimetic agents (e.g., epinephrine)

Moderate Interactions (Monitor Closely): - Antihypertensive drugs - CYP450 substrates (especially CYP2B6 and CYP3A4) - Anticholinergic medications